Intralesional steroid injection for management of acute idiopathic dacryoadenitis: a preliminary result.

Abstract

PURPOSE:

To evaluate the efficacy of intralesional injection of steroid as a new line of therapy in treatment of the acute form of an isolated idiopathic dacryoadenitis.

METHODS:

Five patients with unilateral isolated acute idiopathic dacryoadenitis were included in the study. In 2 patients, the pathology was recurrent. Intralesional injection of 2 to 4 ml betamethasone suspension (1 ml contains 2 mg betamethasone sodium phosphate and 5 mg betamethasone dipropionate) was followed by cold compression for 6 hours. Systemic nonsteroidal anti-inflammatory drugs were given for 2 weeks after the injection.

RESULTS:

Dramatic response was achieved within 7 days after injection in all cases. No patient had recurrence during the follow-up period of 8 to 19 months.

CONCLUSIONS:

The excellent preliminary results make this new line of therapy highly promising. However, more study and long-term follow-up are recommended.

• Authors: Abd El-Nasser A Mohammad
• Journal: Ophthalmic plastic and reconstructive surgery (Ophthalmic Plast Reconstr Surg) Vol. 21 Issue 2 Pg. 138-41 (Mar 2005) ISSN: 0740-9303 [Print] United States
• PMID: 15778669 (Publication Type: Case Reports, Journal Article)

Chemical References

• Glucocorticoids
• Ophthalmic Solutions
• betamethasone sodium phosphate
• betamethasone-17,21-dipropionate
• Betamethasone

Topics

• Acute Disease
• Adolescent
• Adult
• Betamethasone (administration & dosage, analogs & derivatives)
• Child
• Dacryocystitis (diagnostic imaging, drug therapy)
• Drug Therapy, Combination
• Female
• Glucocorticoids (administration & dosage)
• Humans
• Injections, Intralesional
• Male
• Ophthalmic Solutions (administration & dosage)
• Recurrence
• Tomography, X-Ray Computed